Advertisement

Collaboration › Details
Freenome–Biognosys: proteomic technology, 201804– collab enhancing circulating NA cancer test with proteomics data
![]() |
Period | 2018-04-24 |
![]() |
Partner, 1st | Biognosys AG |
Group | Bruker (Group) | |
![]() |
Product | proteomic technology |
Product 2 | cancer test, early detection | |
Record changed: 2025-03-16 |
Advertisement

More documents for Freenome (Group)
- [1] Biognosys AG. (11/9/21). "Press Release: Biognosys Launches Next-Generation Blood Biomarker Discovery Solution". Schlieren....
- [2] Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London....
- [3] Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top